TIBSOVO DIN 02549980
Health Canada record
| Active ingredient(s) | IVOSIDENIB 250 MG |
|---|---|
| Dosage form | Tablet (Immediate-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | |
| Original market date | 28-Oct-2024 |
| Current status date | 28-Oct-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Servier Canada Inc — licence 100542, currently licensed, last inspection rating C (2023-05-31).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 33673 | 2024-07-19 | New Drug Submission (NDS) |
International API supply for IVOSIDENIB
2 active FDA Drug Master Files.
Request a quote for TIBSOVO